ABMD 33.55 Abiomed $ABMD Hit a 52 week high of 34.04

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 10:07 AM

ABMD 33.55 Abiomed $ABMD Hit a 52 week high of 34.04 Closing the day 09:44 at 33.55 -0.21 -0.62% With a day low of 33.55 and a total volume of 12,883.

ABMD Recent Posts: http://investorshangout.com/Abiomed-ABMD-53201/

ABMD Abiomed Recent Headline News

ABIOMED Earnings In Retrospect: Up 6.1% in the Last 18 Days (ABMD)
Comtex SmarTrend(R) - Mon Nov 17, 12:42PM CST
When ABIOMED (NASDAQ:ABMD) reported earnings 18 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.02 on sales of $50.1 million. ABIOMED actually reported earnings of $0.09 per share on sales of $51.9 million, beating EPS estimates by $0.07 and beating revenue estimates by $1.8 million. Shares of ABIOMED have climbed from $31.35 to $33.25, representing a gain of 6.1% since the company reported earnings 18 days ago.
ABMD: 33.67 (-0.09)

Abiomed to Present at the Jefferies 2014 Global Healthcare Conference
GlobeNewswire - Mon Nov 17, 7:18AM CST
Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Robert L. Bowen, Vice President & Chief Financial Officer, will present at the Jefferies 2014 Global Healthcare Conference on November 20, 2014 at 10:40 a.m. GMT. The conference will be held at The Waldorf Hilton London in London, UK.
ABMD: 33.67 (-0.09)

Varian Medical (VAR) Down to Strong Sell on Dismal Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:20PM CST
On Nov 14, 2014, Zacks Investment Research downgraded Varian Medical Systems (VAR) to a Zacks Rank #5 (Strong Sell).
ABMD: 33.67 (-0.09), VAR: 88.34 (+0.73), EW: 127.48 (+1.25), ANGO: 16.82 (-0.03)

ABIOMED (ABMD) Stock: Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:33AM CST
ABIOMED (ABMD) Stock: Moving Average Crossover Alert
ABMD: 33.67 (-0.09)

Thoratec (THOR) Down to Strong Sell on Growing Headwinds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:20PM CST
On Nov 11, 2014, Zacks Investment Research downgraded Thoratec Corp. (THOR) to a Zacks Rank #5 (Strong Sell).
ABMD: 33.67 (-0.09), EW: 127.48 (+1.25), THOR: 30.20 (+1.00), ANGO: 16.82 (-0.03)

Abiomed (ABMD) Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 10:10AM CST
Shares of Abiomed, Inc. (ABMD) have been on the rise since it reported impressive second-quarter fiscal 2015 (ended Sep 30, 2014) results on Oct 30.
ABMD: 33.67 (-0.09), FLDM: 30.68 (+0.67), GMED: 22.95 (+0.52), ANGO: 16.82 (-0.03)

ABIOMED Shares Up 34.3% Since SmarTrend's Buy Recommendation (ABMD)
Comtex SmarTrend(R) - Wed Nov 12, 9:15AM CST
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on October 28th, 2014 at $24.67. In approximately 2 weeks, ABIOMED has returned 34.28% as of today's recent price of $33.13.
ABMD: 33.67 (-0.09)

Mettler-Toledo (MTD) Tops Q3 Earnings on Revenue Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 8:34AM CST
Mettler-Toledo International Inc. (MTD) reported adjusted earnings per share (EPS) of $2.95 for the third quarter of fiscal 2014, which beat the Zacks Consensus Estimate of $2.86. Adjusted EPS also improved 13% from the year-ago quarter.
ABMD: 33.67 (-0.09), FLDM: 30.68 (+0.67), ANGO: 16.82 (-0.03), MTD: 291.48 (+2.51)

Roka Bioscience (ROKA) in Focus: Stock Surges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:11AM CST
Roka Bioscience, Inc. (ROKA) was a big mover last session, as the company saw its shares rise over 19% on the day.
ABMD: 33.67 (-0.09), ROKA: 3.82 (+0.07), EW: 127.48 (+1.25), ANGO: 16.82 (-0.03)

OTC Daily Alert Stock Watch - ABIOMED, Inc. (NASDAQ: ABMD)
WorldStockWire - Mon Nov 10, 12:30PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
ABMD: 33.67 (-0.09)

Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:10AM CST
Despite Volcano (VOLC) provided disappointing revenue guidance for 2014 on account of expected negative foreign exchange impact, management expects accelerated profitability over the near term.
ABMD: 33.67 (-0.09), VOLC: 11.30 (+0.22), EW: 127.48 (+1.25), ANGO: 16.82 (-0.03)

Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:46AM CST
DexCom (DXCM) was a big mover last session, with shares rising over 14% on the day.
ABMD: 33.67 (-0.09), DXCM: 52.50 (+0.76), EW: 127.48 (+1.25), ANGO: 16.82 (-0.03)

VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - Mon Nov 10, 8:23AM CST
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 107.92 (+1.12), ABMD: 33.67 (-0.09), JNJ: 108.78 (+0.48), AMGN: 159.61 (+0.47), EXAS: 23.13 (+0.17), ARAY: 6.96 (+0.14), HOLX: 26.52 (+0.15), PBYI: 216.00 (+4.45)

Update: Abiomed's Q2 Fiscal 2015 Earnings Remained Impressive
Andy Batts - at Seeking Alpha - Sat Nov 08, 4:40PM CST

ABMD: 33.67 (-0.09)

Hologic Beats Q4 Earnings, Sales as All Segments Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 1:50PM CST
Hologic (HOLX) entered into an amended license agreement with Roka Bioscience, which earned a one-time revenue benefit of $20.1 million for Hologic
ABMD: 33.67 (-0.09), DXCM: 52.50 (+0.76), ANGO: 16.82 (-0.03), HOLX: 26.52 (+0.15)

Thoratec Q3 Earnings & Revenues Lag Estimates, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:00AM CST
Following the earnings release, shares of Thoratec Corp. (THOR) declined approximately 3.5% to close at $26.10 yesterday.
ABMD: 33.67 (-0.09), CYNO: 28.10 (+0.25), THOR: 30.20 (+1.00), ANGO: 16.82 (-0.03)

Abiomed (ABMD) Upgraded From Hold to Buy
at The Street - Fri Nov 07, 8:07AM CST
Abiomed (ABMD) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
ABMD: 33.67 (-0.09)

Foundation Medicine Slumps: FMI Tumbles 9.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:59AM CST
Foundation Medicine has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for past 24 hours
ABMD: 33.67 (-0.09), DXCM: 52.50 (+0.76), FMI: 25.48 (+0.28), ANGO: 16.82 (-0.03)

Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:07PM CST
Mindray Medical International Limited (MR) slashed its 2014 financial guidance in the face of increasing uncertainties in currency and other macro developments that could impact its performance in certain key markets.
ABMD: 33.67 (-0.09), FLDM: 30.68 (+0.67), ANGO: 16.82 (-0.03), MR: 31.16 (-0.06)

Abiomed Tops Q2 Earnings, Revenues; FY15 Sales View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:10PM CST
Abiomed Inc. (ABMD) reported second-quarter fiscal 2015 earnings of 9 cents per share, outshining the Zacks Consensus Estimate of 2 cents.
ABMD: 33.67 (-0.09), FLDM: 30.68 (+0.67), BEAT: 8.18 (+0.04), ANGO: 16.82 (-0.03)

Abiomed (ABMD) Stock Research Links

ABMD Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hemlo Mining's Q3 2026: Steady Gold Amid Challenges

Gold Output Amid Operational Hiccups The old saying that rough seas make tough sailors could've been penned for Hemlo Mining during its third quarter this year. They clocked in a notable 25,652 ounces of gold. The revenue charted at $135.5 million, a bit of a slide down the pole if you're comparing to the second quarter, thanks to a dip in gold prices. But let’s weigh...

Quanta Services Gears Up for Major Investor Conferences

Quanta's Busy November and December Heads up, folks, Quanta Services (NYSE:PWR) has some interesting events lined up on their upcoming calendar. This time, they’re heading to a couple of major investor conferences in November and December, and they’re bringing the big names—Duke Austin, Jayshree Desai, and Kip Rupp. This means there might be some juicy developments...

GOFO: Transformative Shifts in U.S. Parcel Dynamics

Once upon a time, the last-mile delivery game in the U.S. was the backyard brawl of a few heavy hitters—USPS, UPS, and FedEx slugging it out for package supremacy. But fast-forward to today's parcel market, and things are looking more like a chaotic street party with Amazon now leading the dance. The scene's thinning in some corners while swelling in others. Let's pull...

Tech Vet's Career Shift: Seniors Helping Seniors Launches

From Silicon Valley Hustle to Heartfelt Care So, Lindsey Keefner, a seasoned pro from Pasadena's tech scene, is ditching the buzz of artificial intelligence to focus on something raw and real—human connection. After two decades of tech gigs, this ex-exec is launching a branch of Seniors Helping Seniors® in Pasadena-Glendale. And let me tell you, this isn't about profit...

Gold Prices Climb; Miners Stick to Guidance Amid Stress

Wham, pow! Gold's climbing up to the skies again. As if the shiny stuff needed more fanfare, there it is, breaking above $4,000 an ounce. Remember when it couldn't hold a candle to $1,500? Now the December gold futures are planting themselves firmly at $4,124.10. That's a healthy leap from Friday's close by $49.20. How about that for a head-turner? Miners Holding the Line...

Burger King Revives Mini-Frenzy with 2026 Advent Calendar

Nostalgia and Miniature Magic: Burger King's Holiday Ploy You ever seen a burger chain stir up more hype around the holidays than Santa in a bright red suit? Well, Burger King's back at it, logging into the nostalgia machine with their teensy-weensy-sized treats—just what frenetic mini fans and collectors clamor for. This pint-sized ploy plays right into the craze for...

Empyrean Eases Public Sector Benefits with OMNIA Deal

In a world where bureaucratic red tape often chokes efficiency, Empyrean throws a lifeline to public sector bodies. They've nabbed a cooperative purchasing contract with OMNIA Partners, dialing down the procurement guts to make benefits administration easier for government and education folks. Streamlining Public Sector Procurement Public sector organizations ain't...

AppLovin Faces Fraud Lawsuit, Investors Alerted

AppLovin's Lawsuit: A Wake-Up Call for Investors The market never forgets, even if some investors might wish reality wasn’t so harsh. On the chopping block this time is AppLovin Corporation (NASDAQ: APP). Seems like their fairy tale with AI turned into a courtroom drama, one that’s throwing a real curveball on those rosy earnings expectations. What's the Case All...

Resideo's AI-Powered Pro-IQ™ Predict: HVAC Revolution

Is AI the Savior for HVAC Breakdowns? You ever been stuck on a freezing night with a busted heater? It's a classic tale: equipment goes south just when you need it most. But what if someone told you AI could catch HVAC issues before they send you running for the wool socks? Enter Resideo Technologies' latest brainchild, Pro-IQ™ Predict. This isn't some run-of-the-mill...

Credit Union Teams Up for Holiday Toy Drive in San Diego

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...